These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 697902)

  • 1. Deamination of dopamine and its 3-O-methylated derivative by human brain monoamine oxidase.
    Roth JA; Feor K
    Biochem Pharmacol; 1978; 27(11):1606-8. PubMed ID: 697902
    [No Abstract]   [Full Text] [Related]  

  • 2. Modification of brain mitochondrial monoamine oxidase activities by hydroxyethylhydrazide of cyanoacetic acid and some other monoamine oxidase inhibitors.
    Baumanis EA; Kalnina IE; Moskvitina TA; Gorkin VZ
    Biochem Pharmacol; 1977 Jun; 26(11):1059-63. PubMed ID: 18152
    [No Abstract]   [Full Text] [Related]  

  • 3. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170
    [No Abstract]   [Full Text] [Related]  

  • 4. [Brain monoamine oxidase in craniocerebral trauma].
    Akopian AS; Promyslov MSh
    Vopr Med Khim; 1984; 30(1):75-7. PubMed ID: 6710942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for dopamine deamination by both type A and type B monoamine oxidase in rat brain in vivo and for the degree of inhibition of enzyme necessary for increased functional activity of dopamine and 5-hydroxytryptamine.
    Green AR; Mitchell BD; Tordoff AF; Youdim MB
    Br J Pharmacol; 1977 Jul; 60(3):343-9. PubMed ID: 890205
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro inhibition of brain mitochondrial monoamine oxidase by 6-hydroxydopamine.
    Youdim MB
    Br J Pharmacol; 1975 Jul; 54(3):403-5. PubMed ID: 1164597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase activity measurements using radioactive substrates.
    Jain M; Sands F; Von Korff RW
    Anal Biochem; 1973 Apr; 52(2):542-54. PubMed ID: 4698849
    [No Abstract]   [Full Text] [Related]  

  • 8. Further studies on the inhibition of monoamine oxidation by monoamine oxidase inhibitors.
    Ghosh SK; Guha SR
    Biochem Pharmacol; 1978 Jan; 27(1):112-4. PubMed ID: 619893
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of selective monoamine oxidase inhibitors on rat brain mitochondrial monoamine oxidase during hyperbaric oxygenation.
    Goroshinskaya IA; Bronovizkaya ZG; Gorkin VZ
    Commun Psychopharmacol; 1977; 1(1):39-47. PubMed ID: 606471
    [No Abstract]   [Full Text] [Related]  

  • 10. The oxidation of dopamine and epinine by the two forms of monoamine oxidase from rat liver.
    Strolin Benedetti M; Sanson G; Bona L; Gallina M; Persiani S; Tipton KF
    J Neural Transm Suppl; 1998; 52():233-8. PubMed ID: 9564622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human brain monoamine oxidase: multiple forms and selective inhibitors.
    Youdim MB; Collins GG; Sandler M; Bevan Jones AB; Pare CM; Nicholson WJ
    Nature; 1972 Mar; 236(5344):225-8. PubMed ID: 4553640
    [No Abstract]   [Full Text] [Related]  

  • 12. The multiple monoamine oxidases.
    Wyatt RJ
    Adv Biochem Psychopharmacol; 1974; 12(0):1-2. PubMed ID: 4529309
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the subcellular localization of monoamine oxidase types A and B and its importance for the deamination of dopamine in the rat brain.
    Urwyler S; von Wartburg JP
    Biochem Pharmacol; 1980 Nov; 29(22):3067-73. PubMed ID: 6779822
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoamine and diamine oxidative deamination in the longitudinal smooth muscle of guinea pig ileum.
    Banchelli G; Raimondi L; Ignesti G; Pirisino R; Buffoni F
    Med Biol; 1985; 63(1):34-9. PubMed ID: 3999819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of some monoamine oxidase inhibitors on deamination of biogenic monoamines by rat liver mitochondrial monoamine oxidase.
    Gorkin VZ; Gridneva LI; Klyashtorin LB; Veryovkina IV; Vina I
    Experientia; 1966 Mar; 22(3):157. PubMed ID: 5960880
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristics of monoamine oxidase activity in mouse brain.
    Hall TR; Figueroa HR
    Pharmacol Res Commun; 1982 May; 14(5):431-41. PubMed ID: 7111359
    [No Abstract]   [Full Text] [Related]  

  • 17. Monoamine oxidase: examination of multiple forms.
    Jain M
    Life Sci; 1977 Jun; 20(12):1925-33. PubMed ID: 329033
    [No Abstract]   [Full Text] [Related]  

  • 18. [Deamination of biogenic amines by mitochondrial monoamine oxidase in human fetal liver].
    Nechushkina TG
    Zh Evol Biokhim Fiziol; 1973; 9(1):91-2. PubMed ID: 4756719
    [No Abstract]   [Full Text] [Related]  

  • 19. Distribution and inhibition characteristics of human brain monoamine oxidase.
    Owen F; Cross AJ; Lofthouse R; Glover V
    Biochem Pharmacol; 1979 Apr; 28(7):1077-80. PubMed ID: 444264
    [No Abstract]   [Full Text] [Related]  

  • 20. [Mechanism of the pharmacological effect of monoamine oxidase inhibitors].
    Gorkin VZ
    Vestn Akad Med Nauk SSSR; 1984; (11):72-5. PubMed ID: 6396999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.